Researchers Boost Cancer-Killing Immune Cells with Specific Signaling for Precise Tumor Attacks
Researchers engineered myeloid cells to deliver interleukin-12 to tumors, activating immune cells and reducing lung metastases in mice.
ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
Researchers engineered myeloid cells to deliver interleukin-12 to tumors, activating immune cells and reducing lung metastases in mice.
Read MoreJAMA published an analysis on the 2025-2026 COVID vaccines’ effectiveness against new Omicron subvariants LP.8.1 and JN.1 in the U.S.
Read MoreColorectal cancer screening among U.S. adults aged 45-49 rose to 34.5% in 2022 following updated screening guidelines.
Read MoreThe Lebanon Health Ministry reported 2,167 deaths from Israeli attacks between March 2 and early April 2026 amid ongoing conflict.
Read MoreEvery AI conversation starts from zero. The tools to fix this have existed for years — vector databases, semantic embeddings, open protocols. But a billion-dollar industry keeps selling subscriptions
Read MoreResearchers developed targeted gum disease treatments that inhibit harmful bacteria while preserving beneficial oral microbes, announced in 2024.
Read MoreResearchers at UC Riverside confirmed vitamin B1 forms a stable carbene in water, proving a 67-year-old hypothesis by Ronald Breslow.
Read MoreResearchers discovered how aggressive triple-negative breast cancer tumors suppress the immune system by hijacking checkpoints and increasing regulatory T cells.
Read MoreA 2026 Weizmann Institute study finds genetics influence 50-55% of human lifespan, doubling previous estimates by analyzing twin data.
Read MoreA Stockholm study found new-onset anemia linked to higher cancer risk and mortality, with 6.2% of men and 2.8% of women developing cancer within 18 months.
Read More